Overexpression of Notch ligand Dll1 in B16 melanoma cells leads to reduced tumor growth due to attenuated vascularization

Cancer Letters

Volumn 309, Issue 2, 2011, Pages 220-227

  Zhang, Jian Ping ^a   Qin, Hong Yan ^a   Wang, Li ^a   Liang, Liang ^a   Zhao, Xing Cheng ^a   Cai, Wei Xia ^a   Wei, Ya Ning ^a   Wang, Chun Mei ^a   Han, Hua ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Delta like 1; Melanoma; Notch signaling

Indexed keywords

DELTA LIKE 1 PROTEIN; MEMBRANE PROTEIN; NOTCH RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH; TUMOR NECROSIS; TUMOR VASCULARIZATION;

ANIMALS; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MELANOMA, EXPERIMENTAL; MICE; NECROSIS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, NOTCH1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79960844408     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.06.008     Document Type: Article

References (41)

1. Bray S.J. Notch signalling: a simple pathway becomes complex. Nat. Rev. Mol. Cell. Biol. 2006, 7:678-689.
2. Artavanis-Tsakonas S., Rand M.D., Lake R.J. Notch signaling: cell fate control and signal integration in development. Science 1999, 284:770-776.
3. Lai E.C. Notch signaling: control of cell communication and cell fate. Development 2004, 131:965-973.
4. Shawber C.J., Kitajewski J. Notch function in the vasculature: insights from zebrafish, mouse and man. Bioessays 2004, 26:225-234.
5. Gridley T. Notch signaling in vascular development and physiology. Development 2007, 134:2709-2718.
6. Villa N., Walker L., Lindsell C.E., Gasson J., Iruela-Arispe M.L., Weinmaster G. Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mech. Dev. 2001, 108:161-164.
7. Hofmann J.J., Iruela-Arispe M.L. Notch signaling in blood vessels: who is talking to whom about what?. Circ. Res. 2007, 100:1556-1568.
8. Krebs L.T., Xue Y., Norton C.R., Shutter J.R., Maguire M., Sundberg J.P., Gallahan D., Closson V., Kitajewski J., Callahan R., Smith G.H., Stark K.L., Gridley T. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 2000, 14:1343-1352.
9. Limbourg F.P., Takeshita K., Radtke F., Bronson R.T., Chin M.T., Liao J.K. Essential role of endothelial Notch1 in angiogenesis. Circulation 2005, 111:1826-1832.
10. Uyttendaele H., Ho J., Rossant J., Kitajewski J. Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. Proc. Natl. Acad. Sci. USA 2001, 98:5643-5648.
11. Carlson T.R., Yan Y., Wu X., Lam M.T., Tang G.L., Beverly L.J., Messina L.M., Capobianco A.J., Werb Z., Wang R. Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice. Proc. Natl. Acad. Sci. USA 2005, 102:9884-9889.
12. Gale N.W., Dominguez M.G., Noguera I., Pan L., Hughes V., Valenzuela D.M., Murphy A.J., Adams N.C., Lin H.C., Holash J., Thurston G., Yancopoulos G.D. Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc. Natl. Acad. Sci. USA 2004, 101:15949-15954.
13. Krebs L.T., Shutter J.R., Tanigaki K., Honjo T., Stark K.L., Gridley T. Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev. 2004, 18:2469-2473.
14. Xue Y., Gao X., Lindsell C.E., Norton C.R., Chang B., Hicks C., Gendron-Maguire M., Rand E.B., Weinmaster G., Gridley T. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum. Mol. Genet. 1999, 8:723-730.
15. Beckers J., Clark A., Wunsch K., Hrabe De Angelis M., Gossler A. Expression of the mouse Delta1 gene during organogenesis and fetal development. Mech. Dev. 1999, 84:165-168.
16. Hrabe de Angelis M., McIntyre J., Gossler A. Maintenance of somite borders in mice requires the Delta homologue DII1. Nature 1997, 386:717-721.
17. Sorensen I., Adams R.H., Gossler A. DLL1-mediated Notch activation regulates endothelial identity in mouse fetal arteries. Blood 2009, 113:5680-5688.
18. Limbourg A., Ploom M., Elligsen D., Sorensen I., Ziegelhoeffer T., Gossler A., Drexler H., Limbourg F.P. Notch ligand Delta-like 1 is essential for postnatal arteriogenesis. Circ. Res. 2007, 100:363-371.
19. Takeshita K., Satoh M., Ii M., Silver M., Limbourg F.P., Mukai Y., Rikitake Y., Radtke F., Gridley T., Losordo D.W., Liao J.K. Critical role of endothelial Notch1 signaling in postnatal angiogenesis. Circ. Res. 2007, 100:70-78.
20. Patel N.S., Li J.L., Generali D., Poulsom R., Cranston D.W., Harris A.L. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Res. 2005, 65:8690-8697.
21. Noguera-Troise I., Daly C., Papadopoulos N.J., Coetzee S., Boland P., Gale N.W., Lin H.C., Yancopoulos G.D., Thurston G. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 2006, 444:1032-1037.
22. Ridgway J., Zhang G., Wu Y., Stawicki S., Liang W.C., Chanthery Y., Kowalski J., Watts R.J., Callahan C., Kasman I., Singh M., Chien M., Tan C., Hongo J.A., de Sauvage F., Plowman G., Yan M. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 2006, 444:1083-1087.
23. Li J.L., Sainson R.C., Shi W., Leek R., Harrington L.S., Preusser M., Biswas S., Turley H., Heikamp E., Hainfellner J.A., Harris A.L. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. Cancer Res. 2007, 67:11244-11253.
24. Segarra M., Williams C.K., Sierra Mde L., Bernardo M., McCormick P.J., Maric D., et al. Dll4 activation of Notch signaling reduces tumor vascularity and inhibits tumor growth. Blood 2008, 112:1904-1911.
25. Zeng Q., Li S., Chepeha D.B., Giordano T.J., Li J., Zhang H., Polverini P.J., Nor J., Kitajewski J., Wang C.Y. Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. Cancer Cell 2005, 8:13-23.
26. Funahashi Y., Hernandez S.L., Das I., Ahn A., Huang J., Vorontchikhina M., Sharma A., Kanamaru E., Borisenko V., Desilva D.M., Suzuki A., Wang X., Shawber C.J., Kandel J.J., Yamashiro D.J., Kitajewski J. A notch1 ectodomain construct inhibits endothelial notch signaling, tumor growth, and angiogenesis. Cancer Res. 2008, 68:4727-4735.
27. Yan M., Callahan C.A., Beyer J.C., Allamneni K.P., Zhang G., Ridgway J.B., Niessen K., Plowman G.D. Chronic DLL4 blockade induces vascular neoplasms. Nature 2010, 463:E6-E7.
28. Folkman J. Tumor angiogenesis: therapeutic implications. New Engl. J. Med. 1971, 285:1182-1186.
29. Folkman J. Fundamental concepts of the angiogenic process. Curr. Mol. Med. 2003, 3:643-651.
30. Neri D., Bicknell R. Tumour vascular targeting. Nat. Rev. Cancer 2005, 5:436-446.
31. Casanovas O., Hicklin D.J., Bergers G., Hanahan D. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 2005, 8:299-309.
32. Kume T. Novel insights into the differential functions of Notch ligands in vascular formation. J. Angiogenesis Res. 2009, 1:8.
33. Dou G.R., Wang Y.C., Hu X.B., Hou L.H., Wang C.M., Xu J.F., Wang Y.S., Liang Y.M., Yao L.B., Yang A.G., Han H. RBP-J, the transcription factor downstream of Notch receptors, is essential for the maintenance of vascular homeostasis in adult mice. FASEB J. 2008, 22:1606-1617.
34. Dufraine J., Funahashi Y., Kitajewski J. Notch signaling regulates tumor angiogenesis by diverse mechanisms. Oncogene 2008, 27:5132-5137.
35. Jakobsson L., Franco C.A., Bentley K., Collins R.T., Ponsioen B., Aspalter I.M., Rosewell I., Busse M., Thurston G., Medvinsky A., Schulte-Merker S., Gerhardt H. Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting. Nat. Cell Biol. 2010, 12:943-953.
36. Roukens M.G., Alloul-Ramdhani M., Baan B., Kobayashi K., Peterson-Maduro J., van Dam H., Schulte-Merker S., Baker D.A. Control of endothelial sprouting by a Tel-CtBP complex. Nat. Cell Biol. 2010, 12:933-942.
37. Liu Z.J., Xiao M., Balint K., Soma A., Pinnix C.C., Capobianco A.J., Velazquez O.C., Herlyn M. Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K/Akt pathways and requires MAML1. FASEB J. 2006, 20:1009-1011.
38. Wang Y.C., He F., Feng F., Liu X.W., Dong G.Y., Qin H.Y., Hu X.B., Zheng M.H., Liang L., Feng L., Liang Y.M., Han H. Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses. Cancer Res. 2010, 70:4840-4849.
39. Lin E.Y., Pollard J.W. Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res. 2007, 67:5064-5066.
40. Hu Y.Y., Zheng M.H., Cheng G., Li L., Liang L., Gao F., Wei Y.N., Fu L.A., Han H. Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells. BMC Cancer 2011, 11:82.
41. Hu X.B., Feng F., Wang Y.C., Wang L., He F., Dou G.R., Liang L., Zhang H.W., Liang Y.M., Han H. Blockade of Notch signaling in tumor-bearing mice may lead to tumor regression, progression, or metastasis, depending on tumor cell types. Neoplasia 2009, 1:32-38.